Dr. rer. nat.
| Scientist | Period | Title of the research project |
|---|---|---|
Dr. rer. nat. Johanna Kaindl | 2017 – 2021 | Advances in human stem cell-based disease models of neurodegeneration |
Dr. rer. nat. Tatyana Pozner | 2016 – 2021 | Deciphering the mechanisms of hereditary spastic paraplegia type11 in stem cell-derived neuronal models |
Dr. rer. nat. Florian Krach | 2016 – 2019 | TDP-43 in sporadic ALS: pathological changes of an RNA-binding protein and consequences on RNA metabolism |
Dr. rer. nat. Katrin Simmnacher | 2015 – 2020 | Investigation of senescence and axonal transport as cellular mechanisms in Parkinson's disease |
Dr. rer. nat. Tania Rizo | 2015 – 2019 | Elucidation of SPG4 associated pathological mechanisms using human iPSZ derived neurons |
Dr. rer. nat. Annika Sommer | 2014 – 2017 | Modeling Neuroinflammation in sporadic Parkinson’s disease |
Dr. rer. nat. Himanshu Kumar Mishra | 2011 – 2016 | Modeling neurodevelopment and cortical dysfunction in SPG11-linked hereditary spastic paraplegia using human induced pluripotent stem cell |
Dr. rer. nat. Steven Jonathan Havlicek | 2010 – 2014
| Modelling SPG4-related hereditary spastic paraplegia using human induced pluripotent stem cells |
Dr. med.
| Scientist | Period | Title of the research project |
|---|---|---|
Dr. med. Anna Brendler | 2017 – 2021 | Differential roles of T cell subsets in α-synuclein aggregation |
Dr. med. Marios Razvan Brandis | 2016 – 2021 | Neuronal vulnerability in human stem cell-based models of Parkinson's disease |
Dr. med. Svenja Stoll | 2015 – 2017 | Influence of the NMDA signaling pathway and of α-synuclein oligomers on adult hippocampal neurogenesis |
Dr. med. Sebastian Schreglmann | 2008 – 2010 | Neurogenesis in the hippocampus in transgenic α-synuclein mouse models |
Dr. med. Christian Hagl | 2005 – 2011 | Effects of the dopamine agonist pramipexole on neurogenesis in adults |
PD Dr. med. Martin Regensburger | 2005 – 2010 | Adult-onset neurogenesis in dystonia |
PD Dr. med. Franz Marxreiter | 2004 – 2010 | Effects of α-synuclein on adult neurogenesis in inducible models of synucleinopathies |
Dr. med. Martin Geyer | 2004 – 2010 | Neurogenesis of the olfactory bulb in the 6-OHDA-PD model |
Dr. med. Johannes Brix | 2005 – 2008 | Olfactory function in Parkinson's disease patients - correlation with disease stage |
Masther thesis
| Scientist | period | Title of the research project |
|---|---|---|
Sebastian Franz Hans Loskarn | 2018 – 2019 | Genetic rescue of SNCA-duplication in human iPSC-derived neurons via CRISPR/Cas9 genome editing |
Julia Riedlberger | 2018 – 2019 | Using human induced pluripotent stem cells and CRISPR/Cas9 to shed light on endoplasmic reticulum and microtubule morphology in hereditary spastic paraplegia type4 |
Elizaveta Gerasimova | 2021 | The development of a human co-culture system of T cells and stem cell-derived midbrain organoids |
Eva Kunzelmann | 2021 | Human stem cell model to investigate inflammatory effects on the gut-brain-axis |
Laura Krumm | 2020 | Designing genome-edited cellular models for precise detection of spatacsin |
Lena Mautner | 2019 | Effects of senescent astrocytes on human induced pluripotent stem cell-derived midbrain dopaminergic neurons in Parkinson's disease |
Jonas Lanfer | 2019 | Characterization of the human microglial response in Parkinson's disease using induced pluripotent stem cell models |
Tom Börstler | 2018 | Phenotypic characterization of neural precursor cells derived from ARID1B and SOX11 gene edited human embryonic stem cells |
Florian Krach | 2016 | Diving into ALS-associated TDP-43 pathology: the role of USP13 and a dysfunctional RNA splicing network |
Naime Denguir | 2014 | Electrophysiological characterization of human neural cells from patients with hereditary spastic paraplegia 4 |
Vanessa Veber | 2013 | Axonal transport in synucleinopathies |
Stefanie Brey | 2012 | Effects of α-synuclein oligomers on membrane function of neurons |
